Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWIFT: Flutiform K-haler in Uncontrolled Asthma
NCT04124510Phase 3Terminated
- Sponsor
- Mundipharma
- Start
- Nov 2019
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate nasal spray, formoterol in asthma, sponsored by Mundipharma. Started Nov 2019; status: terminated.
02
Drugs
fluticasone propionate nasal sprayformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04124510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04124510.